These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 3875906)

  • 21. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
    Arén C; Feddersen K; Rådegran K
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement activation during cardiopulmonary bypass by heparin-protamine interaction.
    Best N; Sinosich MJ; Teisner B; Grudzinskas JG; Fisher MM
    Br J Anaesth; 1984 Apr; 56(4):339-43. PubMed ID: 6608952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine and complement levels in patients undergoing cardiopulmonary bypass.
    Steinberg JB; Kapelanski DP; Olson JD; Weiler JM
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1008-16. PubMed ID: 8246532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complement activation during cardiopulmonary bypass: mechanism and prevention].
    Togashi K; Moro H; Nakazawa S; Okazaki H; Yazawa M; Eguchi S
    Kyobu Geka; 1989 Jul; 42(7):529-32. PubMed ID: 2796088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
    Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
    Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
    Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
    Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
    Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of hepatic mitochondrial redox state on complement biosynthesis and activation during and after cardiopulmonary bypass operations.
    Nomoto S; Shimahara Y; Kumada K; Okamoto Y; Ban T
    Eur J Cardiothorac Surg; 1996; 10(4):273-8. PubMed ID: 8740064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement (C3, C4) and C-reactive protein responses to cardiopulmonary bypass and protamine administration.
    Tulunay M; Demiralp S; Tastan S; Akalin H; Ozyurda U; Corapcioglu T; Akarsu ES
    Anaesth Intensive Care; 1993 Feb; 21(1):50-5. PubMed ID: 8447607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil lactoferrin release during open heart surgery is unrelated to complement activation.
    Shastri KA; Logue GL; Stern MP; Raza S; O'Connor BM; Bovill JJ; Hoover EL
    ASAIO J; 1994; 40(1):56-61. PubMed ID: 8186493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
    Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
    Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased cerebral blood flow velocities assessed by transcranial Doppler examination is associated with complement activation after cardiopulmonary bypass.
    Baufreton C; Pinaud F; Corbeau JJ; Chevailler A; Jolivot D; Ter Minassian A; Henrion D; de Brux JL
    Perfusion; 2011 Mar; 26(2):91-8. PubMed ID: 21173036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of clemastine--H1 histamine receptor blocker in the prevention of haemodynamic disorders after protamine sulfate administration in patients subjected to coronary artery bypass grafting in extracorporeal circulation.
    Lango R; Mroziński P; Wujtewicz M; Suchorzewska J; Rogowski J; Narkiewicz M; Siebert J
    Med Sci Monit; 2000; 6(4):769-75. PubMed ID: 11208407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement (C3, C4) consumption in cardiopulmonary bypass, cardioplegia, and protamine administration.
    Chiu RC; Samson R
    Ann Thorac Surg; 1984 Mar; 37(3):229-32. PubMed ID: 6703805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass.
    Kreutzer DL; McCormick JR; Despins A; Moore M; Rousou JH; Dobbs W; Engleman RN
    J Exp Pathol; 1984; 1(3):183-7. PubMed ID: 6336305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.